Welcome to Stock Market Media Group — We are dedicated to uncovering the stories that make publicly traded companies come alive.  Every company has a story, and it’s our mission to uncover it, and then tell that story to the market. Many public companies are too busy to truly develop their message, so in turn, investors become traders who never feel completely comfortable with holding a position in a company they don’t fully understand. However, we find an educated investor will hold and build a stronger position in companies they do know more about — and that is where we come in.

Content is King, and the team at Stock Market Media Group is delivering powerful and easy to understand corporate stories that gain companies the exposure they need to educate and attract potential new investors through multiple media sources. We’re creating a content rich environment for both Investors and Executives by utilizing our experience and providing a platform for CEO’s to tell their story through the media with our Research Reports, Feature News Articles, CEO Interviews, and Stock Alerts. The Market is waiting — It’s Time to Join Us!

Subscribe For Our Free Alerts


 

Home

Stock Market Media Group… We are a full service Investment Relations firm specializing in Awareness, Research, and Content Development. We can offer you a complete IR solution, or we can deliver our services as needed a la carte.

We offer a platform that allows CEO’s to tell their story through press releases, feature news articles, Research Reports, and CEO Interviews. At the same time, we’re building a library of Research for Investors that allows them to get more informed.

Home

Investment Relations & Awareness… Our Team works tirelessly to bring the market a quality Investment Relations and Market Awareness solution.

We are ready to represent your Company in every facet of Investor Relations from developing your message and telling your story to building your brand and growing your shareholder base. We also strive to bring Investors quality Stock Alerts with our work in Market Awareness via our Alerts Newsletter and Social Network Marketing.


Home

Research Reports Library… Read our Research Reports to get our point of view on the Company’s we find interesting. The comprehensive Reports are written from scratch after a great deal of due diligence, and they offer a cursory look into your investment.

Home

CEO Interviews Library… Listen in as CEO’s take some time out of their busy schedules to sit down with Stock Market Media Group to tell their story.  Our Interviews offer a great chance to hear what’s going on inside the company and what’s on the horizon straight from the CEO.

Home

Feature Articles… Every company has a story, and we work to develop and deliver that story to the public through feature articles focused on a company’s products, its insiders, or the industry these companies call home. Inform the market with our Content Campaigns and grow your audience.


Home

Latest Research Report… Relmada Therapeutics, Inc. (OTCQB: RLMD) In our Latest Report, we introduce you to a biotech with 4 novel drugs in its pipeline. We’ll show you the unique strategy this biopharmaceutical uses to develop drugs, and look into the multi-billion dollar pain market where it competes.

Home

Latest CEO Interview… Nuvilex, Inc. (OTCQB: NVLX)… Listen to Ken Waggoner & Dr. Gerald Crabtree discuss Preclinical Studies, Clinical Trials, Orphan Drug Status, Funding, and much more. Click the Picture Above to Go to the Interview.


 

Recent Market News

Nuvilex, Inc. Engaged in “Cutting Edge” Cannabis Preclinical Studies Using Model Compounds with Cell-in-a-Box

Nuvilex, Inc. Engaged in “Cutting Edge” Cannabis Preclinical Studies Using Model Compounds with Cell-in-a-Box

Written by Ι Stock Market Media Group Staff — October 29, 2014

New York, NY – Nuvilex, Inc. (OTCQB: NVLX)…
Read More

Plandai Biotechnology Receives Approval to Grow Cannabis for Medical Research from Uruguay’s Minister of Public Health

Plandai Biotechnology Receives Approval to Grow Cannabis for Medical Research from Uruguay’s Minister of Public Health

SEATTLE, WA — October 29, 2014 — Plandaí Biotechnology, Inc. (OTCQB: PLPL) (“Plandaí” or “the Company…
Read More

Relmada Therapeutics Adds $15 Million in Capital to Expedite Development of Pain Treatment Drugs

Relmada Therapeutics Adds $15 Million in Capital to Expedite Development of Pain Treatment Drugs

Written by Ι Stock Market Media Group Staff — October 29, 2014

New York, NY – Relmada Therapeutics, Inc. …
Read More

Nuvilex, Inc. Moves Closer to “Bio-Artificial Pancreas” Diabetes Treatment with License for Insulin-Producing Cells

Nuvilex, Inc. Moves Closer to “Bio-Artificial Pancreas” Diabetes Treatment with License for Insulin-Producing Cells

Written by Ι Stock Market Media Group Staff — October 21, 2014

Nuvilex, Inc. (OTCQB: NVLX) has carefully ma…
Read More